PURPOSE: To develop and optimize a (1)H magnetic resonance spectroscopy (MRS) method for measuring brain glutathione (GSH) levels. MATERIALS AND METHODS: Phantom experiments and density operator simulations were performed to determine the optimal TE for measuring GSH at 3T using J-difference spectral editing. In vivo data collected from 11 normal volunteers (43 measurements) and five stroke patients (10 measurements) were processed using a new spectral alignment method (adaptive spectral registration). RESULTS: In phantom experiments and density operator simulations where relaxation effects were ignored, close to maximum GSH signal (2.95 ppm) was obtained at TE approximately 131 msec with minimum N-acetyl-aspartate (NAA) signal interference. Using adaptive spectral registration, GSH levels in healthy volunteers were found to be 1.20 +/- 0.14 mM (mean +/- standard deviation [SD]). GSH levels in stroke patients were found to be 1.19 +/- 0.24 mM in lesion and 1.25 +/- 0.19 mM in contralateral normal tissue. In comparison, the SDs were significantly larger when only the NAA singlet (2.01 ppm) was used as a navigator for spectral alignment. CONCLUSION: Spectral editing using J-differences is a reliable method for measuring GSH levels in volunteers and stroke patients. (c) 2009 Wiley-Liss, Inc.
PURPOSE: To develop and optimize a (1)H magnetic resonance spectroscopy (MRS) method for measuring brain glutathione (GSH) levels. MATERIALS AND METHODS: Phantom experiments and density operator simulations were performed to determine the optimal TE for measuring GSH at 3T using J-difference spectral editing. In vivo data collected from 11 normal volunteers (43 measurements) and five strokepatients (10 measurements) were processed using a new spectral alignment method (adaptive spectral registration). RESULTS: In phantom experiments and density operator simulations where relaxation effects were ignored, close to maximum GSH signal (2.95 ppm) was obtained at TE approximately 131 msec with minimum N-acetyl-aspartate (NAA) signal interference. Using adaptive spectral registration, GSH levels in healthy volunteers were found to be 1.20 +/- 0.14 mM (mean +/- standard deviation [SD]). GSH levels in strokepatients were found to be 1.19 +/- 0.24 mM in lesion and 1.25 +/- 0.19 mM in contralateral normal tissue. In comparison, the SDs were significantly larger when only the NAA singlet (2.01 ppm) was used as a navigator for spectral alignment. CONCLUSION: Spectral editing using J-differences is a reliable method for measuring GSH levels in volunteers and strokepatients. (c) 2009 Wiley-Liss, Inc.
Authors: Kimberly L Chan; Nicolaas A J Puts; Karim Snoussi; Ashley D Harris; Peter B Barker; Richard A E Edden Journal: Magn Reson Med Date: 2016-02-25 Impact factor: 4.668
Authors: S Andrea Wijtenburg; Jamie Near; Stephanie A Korenic; Frank E Gaston; Hongji Chen; Mark Mikkelsen; Shuo Chen; Peter Kochunov; L Elliot Hong; Laura M Rowland Journal: J Magn Reson Imaging Date: 2018-04-16 Impact factor: 4.813
Authors: G C Chiang; X Mao; G Kang; E Chang; S Pandya; S Vallabhajosula; R Isaacson; L D Ravdin; D C Shungu Journal: AJNR Am J Neuroradiol Date: 2017-03-24 Impact factor: 3.825
Authors: S Andrea Wijtenburg; Frank E Gaston; Elena A Spieker; Stephanie A Korenic; Peter Kochunov; L Elliot Hong; Laura M Rowland Journal: Magn Reson Med Date: 2013-10-22 Impact factor: 4.668
Authors: Muhammad G Saleh; Georg Oeltzschner; Kimberly L Chan; Nicolaas A J Puts; Mark Mikkelsen; Michael Schär; Ashley D Harris; Richard A E Edden Journal: Neuroimage Date: 2016-08-14 Impact factor: 6.556
Authors: Mark Mikkelsen; Muhammad G Saleh; Jamie Near; Kimberly L Chan; Tao Gong; Ashley D Harris; Georg Oeltzschner; Nicolaas A J Puts; Kim M Cecil; Iain D Wilkinson; Richard A E Edden Journal: Magn Reson Med Date: 2017-12-07 Impact factor: 4.668